Rectal Cancer News
The daily rectal cancer news is a unique cancer news service that evaluates all aspects of rectal cancer research and reports on the developments that are most important to cancer patients and health care providers. The daily cancer news provides information about emerging options for rectal cancer prevention, early detection and rectal cancer treatment, as well as advances in supportive care and personalized medicine. Supportive care improves quality of life by making rectal cancer treatment more tolerable, and personalized medicine offers the potential for improved treatment outcomes by using specific characteristics of the patient or the cancer to guide cancer treatment decisions. In addition, interested individuals can search the Cancer Consultants Rectal Cancer News Archives to find the results of the cancer studies that led to the care they have been offered.
Rectal Cancer News
Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)
People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading
For Immediate Release March 14, 2013 Colorectal Cancer Advocacy Group, Michael’s Mission, Launches Social Media Platform and is Profiled by Katie Couric Austin, TX– With the launch of... Continue Reading
Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National... Continue Reading
Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains... Continue Reading
The U.S. Multi-Society Task Force on Colorectal Cancer has released a consensus update regarding colonoscopy surveillance—and the guidelines indicate that average-risk patients who have a clean colonoscopy... Continue Reading
Adjuvant chemotherapy appears to offer a survival benefit to patients aged 75 years or older who have surgically resected colorectal cancer, according to the results of a study published in the Journal... Continue Reading
The U.S. Food and Drug Administration (FDA) has approved Zaltrap® (ziv-aflibercept) for use in combination with the FOLFIRI chemotherapy regimen (folinic acid, fluorouracil, and ironotecan) to treat adults... Continue Reading
Among people with Lynch Syndrome, daily aspirin use may cut the risk of colorectal cancer in half. This result—based on longer follow-up of a study that initially found no benefit of aspirin—was published... Continue Reading
There will be nearly 18 million cancer survivors in the United States by 2022, according to a report by the American Cancer Society and the National Cancer Institute: Cancer Treatment & Survivorship... Continue Reading
Combined second-line treatment with Avastin® (bevacizumab) and standard chemotherapy extends survival in patients with advanced colorectal cancer who have received first-line combined Avastin treatment,... Continue Reading
Latest Rectal Cancer News By Stage
Screening and Prevention
Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)
Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading
New Colonoscopy Surveillance Guidelines (October 10, 2012)The U.S. Multi-Society Task Force on Colorectal Cancer has released a consensus update regarding colonoscopy surveillance—and the guidelines indicate that average-risk patients who have a clean colonoscopy can wait 10 years between exams. Colorectal... Continue Reading
Number of Cancer Survivors Will Grow to 18 Million by 2022 (June 25, 2012)There will be nearly 18 million cancer survivors in the United States by 2022, according to a report by the American Cancer Society and the National Cancer Institute: Cancer Treatment & Survivorship Facts & Figures[1] and an accompanying journal... Continue Reading
Sigmoidoscopy Screening Reduces Colorectal Cancer Incidence and Mortality (May 29, 2012)Sigmoidoscopy, a less-invasive screening procedure that examines the lower portion of the bowel, can reduce the risk of developing colorectal cancer or dying from it, according to the results of a study published in the New England Journal of Medicine. Colorectal... Continue Reading
Providing Screening Choices Improves Adherence to Colorectal Cancer Screening (April 16, 2012)Individuals are much more likely to get screened for colorectal cancer when given a choice between colonoscopy and fecal occult blood test (FOBT), according to the results of a study published in the Archives of Internal Medicine.[1] Screening is crucial... Continue Reading
More Screening and PreventionStages I-III
Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)
Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading
Adjuvant Therapy May Offer Survival Benefit in Older Patients with Colorectal Cancer (September 11, 2012)Adjuvant chemotherapy appears to offer a survival benefit to patients aged 75 years or older who have surgically resected colorectal cancer, according to the results of a study published in the Journal of Clinical Oncology. Colorectal cancer is the second... Continue Reading
Rectal Cancer Patients May Benefit from Higher Dose of Preoperative Radiation (October 12, 2011)Among rectal cancer patients treated with chemotherapy and radiation therapy prior to surgery, providing a higher dose of radiation therapy (50 Gy rather than 45 Gy) may reduce the risk of cancer recurrence. These results were presented at the 53rd Annual... Continue Reading
African Americans Most Willing to Exhaust Resources for Life-Extending Care (May 5, 2011)African Americans who are diagnosed with lung or colorectal cancer may be more willing than Whites to expend all personal financial resources in order to extend their lives. Other minority groups also appear more likely than Whites to use personal resources.... Continue Reading
Delay in Chemotherapy Increases Risk of Death in Colorectal Cancer (April 29, 2011)When chemotherapy for colorectal cancer is delayed by more than four weeks following surgery, patients face an increased risk of death. These findings were recently reported at the American Society of Clinical Oncology’s annual Gastrointestinal Cancers... Continue Reading
More Stages I-IIIStage IV
Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)
Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading
Zaltrap Approved for Metastatic Colorectal Cancer (August 15, 2012)The U.S. Food and Drug Administration (FDA) has approved Zaltrap® (ziv-aflibercept) for use in combination with the FOLFIRI chemotherapy regimen (folinic acid, fluorouracil, and ironotecan) to treat adults with metastatic colorectal cancer. Colorectal... Continue Reading
Factors Affecting Quality of Life at the End of Life (July 20, 2012)For people with advanced cancer, quality of life at the end of life—sometimes referred to as “a good death”—may have less to do with medical treatment and more to do with a therapeutic alliance with their physicians, according to the results of... Continue Reading
Continued Avastin Extends Survival After First Progression in Advanced Colorectal Cancer (June 14, 2012)Combined second-line treatment with Avastin® (bevacizumab) and standard chemotherapy extends survival in patients with advanced colorectal cancer who have received first-line combined Avastin treatment, according to the results of a large phase III study... Continue Reading
Regorafenib Shows Promise Against Metastatic Colorectal Cancer (January 19, 2012)The investigational drug regorafenib improves survival and delays cancer progression among patients with metastatic colorectal cancer that has worsened in spite of other treatments. These results will be presented at the 2012 Gastrointestinal Cancers... Continue Reading
More Stage IVRecurrent/Relapsed
Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)
Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading
Zaltrap Approved for Metastatic Colorectal Cancer (August 15, 2012)The U.S. Food and Drug Administration (FDA) has approved Zaltrap® (ziv-aflibercept) for use in combination with the FOLFIRI chemotherapy regimen (folinic acid, fluorouracil, and ironotecan) to treat adults with metastatic colorectal cancer. Colorectal... Continue Reading
Regorafenib Shows Promise Against Metastatic Colorectal Cancer (January 19, 2012)The investigational drug regorafenib improves survival and delays cancer progression among patients with metastatic colorectal cancer that has worsened in spite of other treatments. These results will be presented at the 2012 Gastrointestinal Cancers... Continue Reading
Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival or duration of functional independence but does... Continue Reading
Study Takes Closer Look at Erbitux Efficacy in Patients with Specific KRAS Mutations (November 8, 2010)Although colorectal cancer patients with mutations in the KRAS gene tend not to respond to drugs such as Erbitux® (cetuximab), responsiveness may vary by the specific type of KRAS mutation. These results were published in the Journal of the American... Continue Reading
More Recurrent/Relapsed
